Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NEOLA.STthis companyNeola Medical AB (publ)	SEK 0.48	-7.57×	1.07×	0×	-6.68×	-58.0%	0.0%	0.0%	0.0%	-14.5%	-14.7%	-26.2%	0×	1.65×	-58.93×	5.75×	0.0%	1	4.78	2	C+
ACUC.STAcuCort AB	SEK 0.40	-2.73×	1.12×	103.97×	-1.68×	-33.7%	-2670.0%	-3856.3%	-3812.2%	-41.1%	-41.6%	-34.8%	0×	1.02×	-90.73×	8.08×	0.0%	3	9.81	1	C-
ARCOMA.STArcoma AB	SEK 8.50	20.97×	1.41×	0.8×	4.36×	-14.6%	5.2%	6.6%	3.8%	6.7%	9.3%	12.5%	0×	-2.2×	73.58×	3.49×	0.0%	6	6.68	3	B+
BRAIN.STBrainCool AB (publ)	SEK 1.06	-3.95×	0.85×	4.14×	-3.68×	-1142.9%	-112.9%	-95.1%	-102.3%	-21.1%	-18.8%	-37.7%	0×	1.32×	-8.86×	7.03×	0.0%	2	22.35	1	C-
ICO.STIconovo AB (publ)	SEK 1.10	-1×	0.37×	39.24×	-1.23×	-96.0%	-3959.5%	-3959.5%	-3924.3%	-36.8%	-36.0%	-106.0%	0.04×	0.05×	-97.45×	1.01×	0.0%	4	4.35	2	C+
INTEG-B.STIntegrum AB (publ)	SEK 8.04	-3.96×	1.07×	2.01×	-4.23×	-809.2%	69.2%	-56.4%	-50.7%	-26.9%	-25.4%	-31.6%	0.02×	0.4×	-83.91×	2.77×	0.0%	1	4.67	2	C+
Peer median	—	-2.73×	1.07×	4.14×	-1.68×	-96.0%	-112.9%	-95.1%	-102.3%	-26.9%	-25.4%	-34.8%	0×	0.4×	-83.91×	3.49×	0.0%	3	6.68	2	—